TZ2
Tirzepatide-30mg, 60mg
Blood sugar regulation, fat reduction, and appetite control through dual hormone signaling.
Tirzepatide
A synthetic dual receptor agonist that targets both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is studied for its role in metabolic regulation, insulin sensitivity, and energy balance.
Research Focus
-
Mechanisms of incretin pathway activation and metabolic control.
-
Effects on insulin secretion and glucose utilization.
-
Appetite regulation and reduction in food intake.
-
Decrease in visceral fat mass and enhancement of lipid oxidation.
-
Preservation of lean tissue during fat reduction.
Mechanisms Under Study
-
Dual activation of GIP and GLP-1 receptors for improved glycemic control.
-
Hormonal cross-talk influencing nutrient sensing and energy expenditure.
-
Integrated metabolic effects leading to improved body composition.
Product Information
-
Supplied as a lyophilized sterile powder.
-
Third-party verified for purity, molecular identity, and composition.
-
For laboratory research use only, not for human or animal use.
















